Atlas Trials

The Phase II Study of Bardoxolone Methyl in Patients With Chronic Kidney Disease and Type 2 Diabetes; TSUBAKI Study

Clinical trial NCT02316821 · COMPLETED

Trial details

NCT number
NCT02316821
Sponsor
Kyowa Kirin Co., Ltd.
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Chronic Kidney DiseaseType 2 Diabetes
Start date
2014-12-01
Primary completion
2016-05-01
Enrollment
216

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.